US Stock MarketDetailed Quotes
MRSN Mersana Therapeutics
- 2.210
- -0.310-12.30%
Close Nov 15 16:00 ET
- 2.210
- 0.0000.00%
Post 20:01 ET
273.01MMarket Cap-3683P/E (TTM)
2.610High2.205Low1.01MVolume2.530Open2.520Pre Close2.35MTurnover1.39%Turnover RatioLossP/E (Static)123.53MShares6.28052wk High276.25P/B161.23MFloat Cap1.22052wk Low--Dividend TTM72.96MShs Float29.090Historical High--Div YieldTTM16.07%Amplitude0.801Historical Low2.322Avg Price1Lot Size
Mersana Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -35.61%155.17M | -43.21%162.74M | -33.14%183.15M | -25.52%209.08M | -25.52%209.08M | -16.94%240.99M | 27.30%286.59M | 19.07%273.92M | 57.75%280.71M | 57.75%280.71M |
| -Cash and cash equivalents | -57.66%78.87M | -54.17%59M | -38.79%75.19M | 35.44%174.56M | 35.44%174.56M | 1.20%186.28M | -4.88%128.73M | -46.61%122.83M | -27.57%128.89M | -27.57%128.89M |
| -Short-term investments | 39.49%76.3M | -34.28%103.74M | -28.55%107.96M | -77.26%34.52M | -77.26%34.52M | -48.41%54.7M | 75.81%157.86M | --151.09M | --151.83M | --151.83M |
| Receivables | --1M | --1.57M | ---- | --0 | --0 | --0 | --0 | --0 | --30M | --30M |
| -Accounts receivable | --1M | --1.57M | ---- | --0 | --0 | --0 | --0 | --0 | --30M | --30M |
| Other current assets | -49.89%4.39M | -55.70%4.65M | -44.32%4.39M | -41.54%4.97M | -41.54%4.97M | -11.69%8.75M | -12.15%10.5M | -30.89%7.89M | -22.32%8.51M | -22.32%8.51M |
| Total current assets | -35.71%160.56M | -43.13%168.96M | -33.45%187.54M | -32.94%214.06M | -32.94%214.06M | -16.76%249.74M | 25.31%297.09M | 16.70%281.81M | 68.99%319.22M | 68.99%319.22M |
| Non current assets | ||||||||||
| Net PPE | -36.99%8M | -31.42%9.19M | -24.95%10.36M | -20.30%11.53M | -20.30%11.53M | -10.63%12.69M | -7.92%13.4M | -5.15%13.8M | -2.67%14.46M | -2.67%14.46M |
| -Gross PPE | -36.99%8M | -31.42%9.19M | -24.95%10.36M | -7.24%20.6M | -7.24%20.6M | -10.63%12.69M | -7.92%13.4M | -5.15%13.8M | -1.50%22.2M | -1.50%22.2M |
| -Accumulated depreciation | ---- | ---- | ---- | -17.15%-9.07M | -17.15%-9.07M | ---- | ---- | ---- | -0.78%-7.74M | -0.78%-7.74M |
| Other non current assets | 104.60%978K | 89.17%978K | -18.71%478K | -27.69%478K | -27.69%478K | -22.40%478K | -28.59%517K | -73.83%588K | -71.94%661K | -71.94%661K |
| Total non current assets | -31.85%8.97M | -26.94%10.17M | -24.69%10.84M | -20.62%12M | -20.62%12M | -11.12%13.17M | -8.90%13.91M | -14.34%14.39M | -12.15%15.12M | -12.15%15.12M |
| Total assets | -35.52%169.53M | -42.40%179.13M | -33.03%198.37M | -32.39%226.06M | -32.39%226.06M | -16.50%262.9M | 23.24%311M | 14.69%296.2M | 62.21%334.34M | 62.21%334.34M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -84.30%2.03M | -82.19%3.01M | -83.00%3.09M | -47.54%7.32M | -47.54%7.32M | -5.72%12.95M | 107.38%16.92M | 85.74%18.16M | 13.23%13.95M | 13.23%13.95M |
| -accounts payable | -84.30%2.03M | -82.19%3.01M | -83.00%3.09M | -47.54%7.32M | -47.54%7.32M | -5.72%12.95M | 107.38%16.92M | 85.74%18.16M | 13.23%13.95M | 13.23%13.95M |
| Current accrued expenses | -36.47%18.63M | -46.87%17.78M | -51.34%15.86M | -49.29%21.9M | -49.29%21.9M | -28.84%29.32M | -2.30%33.47M | 18.61%32.59M | 50.38%43.18M | 50.38%43.18M |
| Current debt and capital lease obligation | 384.89%15.21M | 296.26%11.99M | 201.48%8.76M | 90.67%5.34M | 90.67%5.34M | 16.31%3.14M | 16.71%3.03M | 20.80%2.9M | 21.49%2.8M | 21.49%2.8M |
| -Current debt | --11.46M | --8.33M | --5.21M | --2.08M | --2.08M | ---- | ---- | ---- | ---- | ---- |
| -Current capital lease obligation | 19.64%3.75M | 20.79%3.65M | 22.14%3.55M | 16.23%3.25M | 16.23%3.25M | 16.31%3.14M | 16.71%3.03M | 20.80%2.9M | 21.49%2.8M | 21.49%2.8M |
| Current deferred liabilities | 45.29%31.37M | 43.15%29.35M | -10.95%25.62M | -8.05%28.15M | -8.05%28.15M | -30.18%21.59M | -21.85%20.5M | 73.54%28.77M | 676.12%30.61M | 676.12%30.61M |
| Other current liabilities | 12.81%1.06M | -94.35%57K | -90.76%91K | -5.25%938K | -5.25%938K | 295.36%937K | 331.20%1.01M | 326.41%985K | 314.23%990K | 314.23%990K |
| Current liabilities | 0.54%68.3M | -17.00%62.18M | -35.97%53.41M | -30.48%63.64M | -30.48%63.64M | -23.49%67.93M | 4.83%74.92M | 47.71%83.4M | 92.61%91.53M | 92.61%91.53M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -47.78%16.29M | -36.51%20.32M | -25.80%24.32M | -15.54%28.3M | -15.54%28.3M | -8.61%31.21M | -8.12%32.01M | -7.07%32.78M | -6.60%33.5M | -6.60%33.5M |
| -Long term debt | -44.35%14M | -32.02%17.05M | -19.62%20.1M | -7.14%23.15M | -7.14%23.15M | 1.22%25.16M | 1.22%25.08M | 1.22%25M | 1.23%24.93M | 1.23%24.93M |
| -Long term capital lease obligation | -62.07%2.3M | -52.78%3.27M | -45.66%4.22M | -39.95%5.15M | -39.95%5.15M | -34.88%6.05M | -31.13%6.93M | -26.44%7.77M | -23.76%8.58M | -23.76%8.58M |
| Non current deferred liabilities | -24.79%83.87M | -23.32%87.57M | -20.38%92.02M | -16.98%97.17M | -16.98%97.17M | 9.95%111.5M | 877.38%114.2M | 351.14%115.58M | --117.04M | --117.04M |
| Other non current liabilities | -68.66%21K | 723.68%626K | 355.71%638K | -72.91%55K | -72.91%55K | -74.81%67K | -76.83%76K | -64.01%140K | -79.16%203K | -79.16%203K |
| Total non current liabilities | -29.83%100.18M | -25.82%108.52M | -21.22%116.98M | -16.74%125.52M | -16.74%125.52M | 5.12%142.78M | 212.25%146.28M | 142.34%148.5M | 309.12%150.75M | 309.12%150.75M |
| Total liabilities | -20.04%168.48M | -22.83%170.7M | -26.53%170.39M | -21.93%189.16M | -21.93%189.16M | -6.19%210.71M | 86.96%221.2M | 96.96%231.9M | 187.17%242.28M | 187.17%242.28M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%12K | 0.00%12K | 9.09%12K | 9.09%12K | 9.09%12K | 20.00%12K | 20.00%12K | 22.22%11K | 57.14%11K | 57.14%11K |
| -common stock | 0.00%12K | 0.00%12K | 9.09%12K | 9.09%12K | 9.09%12K | 20.00%12K | 20.00%12K | 22.22%11K | 57.14%11K | 57.14%11K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -9.25%-881.44M | -13.69%-869.94M | -18.96%-845.67M | -26.22%-826.36M | -26.22%-826.36M | -32.32%-806.82M | -39.13%-765.16M | -42.82%-710.85M | -45.33%-654.69M | -45.33%-654.69M |
| Paid-in capital | 2.73%882.45M | 2.74%878.42M | 12.72%873.73M | 15.58%863.24M | 15.58%863.24M | 22.68%859M | 24.98%855M | 21.44%775.13M | 30.53%746.89M | 30.53%746.89M |
| Gains losses not affecting retained earnings | 2,400.00%25K | -44.90%-71K | -850.00%-90K | 107.24%11K | 107.24%11K | 100.43%1K | 61.11%-49K | --12K | ---152K | ---152K |
| Total stockholders'equity | -97.99%1.05M | -90.62%8.43M | -56.47%27.99M | -59.91%36.9M | -59.91%36.9M | -42.15%52.2M | -33.00%89.8M | -54.25%64.29M | -24.38%92.06M | -24.38%92.06M |
| Total equity | -97.99%1.05M | -90.62%8.43M | -56.47%27.99M | -59.91%36.9M | -59.91%36.9M | -42.15%52.2M | -33.00%89.8M | -54.25%64.29M | -24.38%92.06M | -24.38%92.06M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data